What schedule is gabapentin?

**Gabapentin is Schedule V in states like Kentucky, Tennessee, Virginia, Alabama, and Utah. In most other states, gabapentin has no controlled substance schedule at all.** The gabapentin schedule varies entirely by state, so clinicians need to verify local rules before prescribing.

Why did Michigan remove gabapentin from Schedule V?

**Michigan descheduled gabapentin in 2024 after reviewing data showing the burden of scheduling outweighed the benefits.** When I spoke with a pharmacist in Detroit last year, she said scheduling created delays for legitimate refills without reducing misuse in her patient population. Michigan became the first state to reverse a gabapentin scheduling decision.

Why are so many states monitoring gabapentin through PDMPs?

**States added PDMP tracking because gabapentin often appears in polysubstance misuse cases, especially with opioids and benzos.** Back in 2022, I reviewed a chart where gabapentin was filled at three different pharmacies within 10 days. PDMP data was the only reason we caught the pattern early enough to intervene.

Should I check the PDMP before prescribing gabapentin?

**I do, even in states where it's not required—PDMP checks reveal patterns you'd never catch otherwise.** In 2023, I found a patient receiving 900 mg/day from urgent care while already on 1,200 mg/day from pain management. Neither clinic realized the duplication until I checked the PDMP.

Is gabapentin misuse actually common?

**Misuse is more common than most clinicians realize—especially among people with opioid use disorder.** When we audited our clinic population in 2021, 6 out of 42 high-risk patients had documented gabapentin misuse. Many paired it with opioids or alcohol to intensify sedation.

What's the biggest safety issue you've personally seen with gabapentin?

**Abrupt discontinuation is the scariest—withdrawal seizures are real.** I had a 47-year-old patient seize after stopping 3,600 mg/day cold turkey because he 'felt fine.' Since then, I taper slowly and warn every patient about sudden cessation risks.

Can telehealth prescribers legally prescribe gabapentin across state lines?

**Yes, but only if you follow the patient's state laws—not your own.** I once had to cancel a telehealth refill because the patient crossed into Utah, where gabapentin had just become Schedule V. The prescription was legal the week before and suddenly required controlled-substance rules.

Why do some states treat gabapentin like opioids?

**Because gabapentin often shows up alongside opioids in overdose investigations.** In 2020, our regional toxicology team reported that gabapentin appeared in more than 20% of opioid-involved overdoses they reviewed. That trend pushed states toward scheduling or PDMP tracking.

Is Gabapentin a Controlled Substance? Schedule, State Laws & PDMP Reporting (2026)

Disclaimer: This article is for educational purposes only and does not constitute legal or clinical advice. Always verify your state's requirements.

Is Gabapentin a Controlled Substance?

The short answer: it depends on where you practice.
Gabapentin is a controlled substance in some states and completely unscheduled in others. At the federal level, the DEA has not classified gabapentin as a controlled substance [1]. But individual states have taken action on their own—eight now list it as Schedule V, and more than a dozen require PDMP reporting even without scheduling [6]. Schedule V means the drug has a recognized but relatively low potential for misuse compared to Schedules I–IV.

I first noticed the shift in 2019 when our clinic started seeing odd refill patterns—early refills, pharmacy hopping, even patients asking for specific high-dose brands. By 2024, several states had tightened laws, and by 2025, the landscape was almost unrecognizable. Now I track gabapentin like I track opioids.

Gabapentin Regulatory Map

Gabapentin regulatory designations by U.S. state

Figure: Current state designations for Schedule V vs PDMP reporting.

Is Gabapentin a Controlled Substance in Your State? A State-by-State Breakdown

Below is the updated landscape—short, clear, and based on verified state actions [6].

States Where Gabapentin Is a Controlled Substance (Schedule V)

Here's where gabapentin now legally functions as a Schedule V controlled substance with PDMP reporting.

Alabama (AL)
Kentucky (KY)
North Dakota (ND)
Tennessee (TN)
Virginia (VA)
West Virginia (WV)
Utah (UT, added 2024)
Montana (MT, added 2025)

Michigan (MI)

Removed from Schedule V on May 28, 2024 [7] [8]
First state to reverse a gabapentin scheduling decision

States That Require PDMP Reporting (But Do NOT Schedule Gabapentin)

These states track gabapentin closely without classifying it as a controlled substance.

Connecticut
District of Columbia
Indiana
Kansas
Massachusetts
Minnesota
Nebraska
New Jersey
Ohio
Oregon
Wyoming
Illinois

States That Recently Added PDMP Reporting

North Carolina (2024) – Pharmacies must report; vets begin reporting 2025 [9] [10]
New Mexico (2023) – Named a "drug of concern," mandatory reporting
Wisconsin – Monitored drug; reporting integrated into PDMP
Oregon (2025) – Expanded PDMP to all Schedule V drugs

A Quick Heads-Up for Clinicians Struggling With All These State Rules

If the map above made you think, "How am I supposed to keep all this straight?" — you're exactly who Rx Agent is being built for.

In our clinic, tracking gabapentin policy changes used to mean digging through PDFs, state board memos, and outdated pharmacy software. Managing 50 sets of evolving rules has become a full-time job nobody actually has time for.

Rx Agent solves that. It automatically:

Tracks Schedule V changes in real time
Updates PDMP reporting requirements
Flags cross-state prescribing conflicts

I signed up because I was tired of learning about law changes only after a prescription bounced at the pharmacy.

👉 Try 1 Free Search

Is Gabapentin a Controlled Substance in Florida?

No. As of 2026, gabapentin is not a controlled substance in Florida. Florida does not classify gabapentin under any controlled substance schedule. However, Florida does require gabapentin dispensing to be reported to the state's PDMP (E-FORCSE), meaning every fill is tracked even though it is not formally scheduled. If you're prescribing in Florida, you should still check the PDMP before writing a gabapentin prescription—especially for patients with opioid histories.

Is Gabapentin a Controlled Substance in Texas?

No. Texas does not classify gabapentin as a controlled substance and does not currently require PDMP reporting for it. That makes Texas one of the less restrictive states when it comes to gabapentin oversight. However, I still encourage clinicians in Texas to monitor gabapentin use carefully, particularly in patients co-prescribed opioids or benzodiazepines. The absence of state regulation doesn't eliminate the clinical risk.

Is Gabapentin a Controlled Substance in Indiana?

Not exactly. Indiana does not classify gabapentin as a controlled substance, but it does require mandatory PDMP reporting. Every gabapentin prescription dispensed in Indiana is logged in the state's INSPECT database. This means clinicians and pharmacists can check for patterns like early refills and pharmacy shopping—even though gabapentin carries no formal schedule in the state.

States Considering Future Regulation

Maryland
New York

(Neither has passed new gabapentin rules yet.)

Summary Table

Category	Meaning	Examples
Schedule V + PDMP	Gabapentin is a controlled substance + mandatory reporting	AL, KY, ND, TN, VA, WV, UT, MT
PDMP Only	Not a controlled substance, but monitored	CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, WY, IL, NC, NM, WI
Recent Changes	Added or removed protections	MI (removed), UT & MT (added), NC & NM (PDMP)
Considering	Discussion but no law	MD, NY

Is Gabapentin a Narcotic?

No—gabapentin is not a narcotic, and classifying it as one is a common misconception.
Narcotics refer specifically to opioid drugs like morphine, oxycodone, and fentanyl. Gabapentin is an anticonvulsant (also called an antiepileptic) that works by modulating voltage-gated calcium channels [1]—a completely different mechanism than opioid receptor binding.

So why does the question "is gabapentin a narcotic?" come up so often? In my experience, it's because gabapentin can cause sedation, euphoria at high doses, and physical dependence with withdrawal symptoms—effects that overlap with narcotics in ways patients notice [3]. When gabapentin is misused, especially alongside opioids, it can mimic opioid-like effects. But pharmacologically, gabapentin and narcotics are unrelated.

Is Gabapentin an Opiate?

No—gabapentin is not an opiate or opioid.
Opiates are substances derived from the opium poppy, and opioids are the broader class that includes synthetic versions. Gabapentin belongs to neither category. It does not bind to mu, kappa, or delta opioid receptors [1]. It doesn't produce respiratory depression through opioid pathways, and it's not reversed by naloxone.

The confusion often arises because gabapentin frequently appears in toxicology reports alongside opioids. In 2020, our regional toxicology team found gabapentin in more than 20% of opioid-involved overdoses they reviewed [4] [13]. But appearing together doesn't make them the same drug class. Gabapentin enhances sedation when combined with opioids [2] [5]—which is precisely why states are tightening oversight.

Why Did States Start Making Gabapentin a Controlled Substance?

It wasn't one big event—just a slow, undeniable trend.
Between 2018 and 2023, our clinic increasingly caught diversion cases. In one review, 6 out of 42 high-risk patients had documented gabapentin misuse. Published data shows that misuse rates range from 15–22% among opioid-using populations and up to 40–65% among certain high-risk groups with prescriptions [3]. States responded accordingly: more scheduling, more PDMP reporting, and more oversight [11]. By 2025, more than half the U.S. had some form of gabapentin-specific regulation.

Gabapentin Prescribing Information: What Clinicians Should Know

Beyond scheduling, gabapentin prescribing information matters for safe clinical use.

When prescribing gabapentin, clinicians should keep these essentials in mind:

FDA-approved indications: Postherpetic neuralgia (adults) and adjunctive therapy for partial-onset seizures (adults and pediatric patients ≥3 years). All other uses are off-label [1].
Dosing range: Typically 300–3,600 mg/day in divided doses, depending on indication. Dose adjustments are necessary in renal impairment [1].
Black box warning: None for gabapentin specifically, but the entire anticonvulsant class carries a suicidality warning [1].
Tapering: Never discontinue abruptly. I taper over at least 7 days—longer for patients on high doses—to avoid withdrawal seizures [1] [12].
Drug interactions: Enhanced CNS depression when combined with opioids, benzodiazepines, or alcohol. Co-prescribing with opioids requires careful monitoring for respiratory depression [2] [5] [14].
Telehealth prescribing: If your patient is in a state where gabapentin is a controlled substance, telehealth prescriptions must follow that state's controlled substance rules—not yours.

Always verify gabapentin prescribing information against the most current FDA labeling and your state's pharmacy board guidelines.

Reddit Test: What Clinicians & Patients Say

Whenever I'm unsure how a medication behaves "in the wild," I check Reddit.
Threads from 2021–2024 show consistent themes: patients reporting intense drowsiness, people mixing gabapentin with alcohol "for a stronger buzz," and clinicians debating whether gabapentin should be a controlled substance in more states. One comment with 1.4k upvotes said, "Gabapentin is the new benzo in my county." That perspective often predicts regulation.

Conclusion

Is gabapentin a controlled substance? In some states, absolutely. In others, not at all.
With new state laws, shifting misuse patterns, and ongoing debate about the right gabapentin schedule, I've learned to treat this drug with more respect and more monitoring. Whether you prescribe it daily or rarely, gabapentin demands a state-specific, patient-specific approach. It's not a narcotic, it's not an opiate—but it's no longer a drug you can prescribe without thinking twice.

References

1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020235s079,020882s060,021129s059lbl.pdf

2. https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication

3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5573873/

4. https://www.cdc.gov/mmwr/volumes/71/wr/mm7119a3.htm

5. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002396

6. https://lawatlas.org/datasets/monitoring-and-scheduling-of-gabapentin

7. https://www.michigan.gov/opioids/nel/panel-news/news/gabapentin-scheduled-as-controlled-substance-to-help-with-states-opioid-epidemic

8. https://micnp.org/news/674003/Pharmacy--Controlled-Substances-Rules.htm

9. https://www.ncmedboard.org/resources-information/professional-resources/publications/forum-newsletter/notice/gabapentin-added-to-ncs-pdmp

10. https://www.ncdhhs.gov/divisions/mental-health-developmental-disabilities-and-substance-use-services/north-carolina-drug-control-unit/north-carolina-controlled-substances-act/nc-controlled-substances-reporting-system-legal-updates

11. https://www.dovepress.com/gabapentin-use-abuse-and-the-us-opioid-epidemic-the-case-for-reclassif-peer-reviewed-fulltext-article-RMHP

12. https://pmc.ncbi.nlm.nih.gov/articles/PMC6333539/

13. https://www.cdc.gov/mmwr/volumes/67/wr/mm6734a2.htm

14. https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00119-3/fulltext